The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-01-25. Anything still debated is marked as such rather than presented as settled.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Based on the C-terminal region of human growth hormone. |
| Amino acid length | 16 residues | Often described as hGH fragment 176-191. |
| Appearance | Lyophilized powder | Typically white to off-white; exact appearance depends on grade. |
| Solubility | Soluble in water | Aqueous solubility depends on pH, ionic strength, and preparation. |
| Typical storage | -20 °C or lower | Lyophilized peptide is usually kept cold and dry; solutions may require freezing. |
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
NASA Radioisotope Power Systems website – RTG page NASA JPL briefing, Expanding Frontiers with Radioisotope Power Systems – gives RTG information and a link to a longer presentation SpaceViews: The Cassini RTG Debate Stirling Radioisotope Generator DOE contributions – good links Idaho National Laboratory – Producer of RTGs Idaho National Laboratory MMRTG page with photo-based "virtual tour"
(CH2CH2)O + C2H5OH → HO–CH2CH2–OC2H5 2 (CH2CH2)O + C2H5OH → HO–CH2CH2–O–CH2CH2–OC2H5 Reactions with lower alcohols occur less actively than with water and require more severe conditions, such as heating to 160 °C (320 °F) and pressurizing to 3 MPa (440 psi) and adding an acid or alkali catalyst. Reactions of ethylene oxide with fatty alcohols proceed in the presence of sodium metal, sodium hydroxide, or boron trifluoride and are used for the synthesis of surfactants.
=== VGLUTs === Three types of vesicular glutamate transporters are known, VGLUTs 1–3 (SLC17A7, SLC17A6, and SLC17A8 respectively) and the novel glutamate/aspartate transporter sialin. These transporters pack the neurotransmitter into synaptic vesicles so that they can be released into the synapse. VGLUTs are dependent on the proton gradient that exists in the secretory system (vesicles being more acidic than the cytosol). VGLUTs have only between one hundredth and one thousandth the affinity for glutamate that EAATs have. Also unlike EAATs, they do not appear to transport aspartate.
Sources: en.wikipedia.org
Drostanolone propionate produces considerably less virilization in women compared to equal doses of testosterone propionate. However, since the given dosage for breast cancer was relatively high (200 mg/twice a week), mild virilization including oily skin, acne, voice deepening, hirsutism, and clitoral enlargement could still occur, and marked virilization could manifest with long-term therapy. The drug has no estrogenic activity and hence has no propensity for causing gynecomastia (in males) or fluid retention. Drostanolone propionate is not known to pose a risk of hepatotoxicity.
=== Comments on Julian Assange sexual assault allegations === Galloway was criticised for comments he made in August 2012 on the legal case involving Wikileaks' Julian Assange in a podcast released on YouTube. He stated that "I think that Julian Assange's personal sexual behaviour is something sordid, disgusting, and I condemn it." Swedish prosecutors wanted to question Assange in relation to the alleged sexual assault of two women, an accusation he has rejected. Galloway continued by stating: "But even taken at its worst, if the allegations made by these two women were true, 100 per cent true, and even if a camera in the room captured them, they don't constitute rape, at least not rape as anyone with any sense can possibly recognise it." He also stated that "not everybody needs to be asked prior to each insertion." He continued by saying that the allegations, even if true, "don't constitute rape" because initiating sex with someone who is asleep after a sexual encounter the previous night is not rape (one of the women, he said, "woke up to him [Assange] having sex with her again – something which can happen, you know"). He said that Assange's alleged actions amounted to no more than "bad sexual etiquette", and he did not believe the women's story anyway. According to British barrister Felicity Gerry, Galloway's description of rape is not correct under English law.
In 2013, when a Salvadoran woman known as "Beatriz" was denied an abortion despite doctors saying that she would die in childbirth, Bukele called those who denied her an abortion "fanatics" ("fanáticos"). Bukele stated in October 2018 that he only supported abortion in cases where the mother's life was at risk, and expressed opposition to abortion on demand. Shortly after becoming president, he opposed abortion under any circumstances. In an interview with Puerto Rican rapper Residente, Bukele said that "someday, we are going to recognize that [abortion] is a great genocide" ("algún día, nos vamos a dar cuenta de que es un gran genocidio"). Bukele's August 2021 constitutional-reform proposal considered legalizing abortion in cases where the mother's life was at risk, adding that the proposal would have recognized the right to life for mother and child. He changed his mind the following month, saying that abortion would not be decriminalized and recognizing the "RIGHT TO LIFE (from the moment of conception)" of the unborn. Bukele also ruled out euthanasia.
Sources: en.wikipedia.org
Uranium-233 is a fissile isotope that is bred from thorium-232 as part of the thorium fuel cycle. 233U was investigated for use in nuclear weapons and as a reactor fuel. It was occasionally tested but never deployed in nuclear weapons and has not been used commercially as a nuclear fuel. It has been used successfully in experimental nuclear reactors and has been proposed for much wider use as a nuclear fuel. It has a half-life of around 160,000 years. Uranium-233 is produced by neutron irradiation of thorium-232. When thorium-232 absorbs a neutron, it becomes thorium-233, which has a half-life of only 22 minutes. Thorium-233 beta decays into protactinium-233. Protactinium-233 has a half-life of 27 days and beta decays into uranium-233; some proposed molten salt reactor designs attempt to physically isolate the protactinium from further neutron capture before beta decay can occur. Uranium-233 usually fissions on neutron absorption but sometimes retains the neutron, becoming uranium-234. The capture-to-fission ratio is smaller than the other two major fissile fuels, uranium-235 and plutonium-239; it is also lower than that of short-lived plutonium-241, but bested by very difficult-to-produce neptunium-236.
Émile Zuckerkandl (July 4, 1922 – November 9, 2013) was an Austrian-born French biologist considered one of the founders of the field of molecular evolution. He introduced, with Linus Pauling, the concept of the "molecular clock", which enabled the neutral theory of molecular evolution.
=== The Copa América final (1975) === The renamed and decentralised 1975 Copa América produced Colombia's first deep run in a continental tournament. Coached by Efraín Sánchez, the goalkeeper of the 1962 squad, Colombia won all four group matches against Paraguay and Ecuador, scoring seven and conceding one. In the semi-final they overwhelmed the defending champions Uruguay 3–0 at the Estadio El Campín through Edgar Angulo, Ortiz and Ernesto Díaz; the return at the Estadio Centenario finished 1–0 to Uruguay, whose Fernando Morena converted an early penalty before being sent off and whose team missed two further spot-kicks. With the sides level on points, Colombia advanced on goal difference. The final against Peru was the first in the competition's history to be decided over multiple legs. Ponciano Castro settled the opening match in Bogotá on 16 October with a long-range strike; Peru answered a week later at the Estadio Nacional in Lima, Juan Carlos Oblitas and Oswaldo Ramírez scoring inside the first half for a 2–0 win that levelled the tie on points and forced a decider on neutral ground. At the Estadio Olímpico in Caracas on 28 October, Hugo Sotil — flown in from Barcelona — scored the only goal before 30,000 spectators, and Peru claimed a second continental title. Ernesto Díaz finished as the tournament's joint leading scorer with four goals, a total that still ranks among the highest by a Colombian at the Copa América.
Sources: en.wikipedia.org
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.
No. It represents only a short portion of the hGH sequence and lacks the full hormone's structure. As a result, its biological activity and regulatory status differ from those of prescription hGH.
The exact peptide is not typically described as a circulating hormone; it is a synthetic construct based on a natural sequence. Fragments of hGH can exist in laboratory or metabolic contexts, but AOD-9604 itself is manufactured for research.
No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.